John de Groot

机构：Henry Ford Health, University of California, San Francisco · ORCID：0000-0003-1454-6461

发表论文 616 篇 · 总被引 20610 次 · h-index 71

代表论文

• Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial (2025 · Nature Communications · 被引 29)
• Gabapentinoids confer survival benefit in human glioblastoma (2025 · Nature Communications · 被引 24)
• Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial (2026 · Journal of Clinical Oncology · 被引 10)
• The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: a RANO perspective (2025 · Neuro-Oncology · 被引 9)
• Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy (2025 · JAMA Oncology · 被引 9)
• Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium (2025 · Neuro-Oncology · 被引 8)